Bradley Evan Burnam - 01 Apr 2026 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: TTRX
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 08:07:27 UTC
Prior SEC filing: 07 Oct 2025
Next SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Bradley Burnam

Key filing fact

Bradley Evan Burnam filed Form 4 for Turn Therapeutics Inc. (TTRX) on 03 Apr 2026.

Key facts

This page summarizes Bradley Evan Burnam's Form 4 filing for Turn Therapeutics Inc. (TTRX).
1 reported transaction and 2 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 08:07.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0002087366 Primary reporting owner

Burnam Bradley Evan

Relationship: Chief Executive Officer, Director, 10%+ Owner
Address: C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE
Signature: /s/ Bradley Burnam
Signature date: 03 Apr 2026

CIK 0002087363

BEB Holdings, LLC

Relationship: 10%+ Owner
Address: C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE
Signature: /s/ Bradley Burnam, sole member of BEB Holdings, LLC
Signature date: 03 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TTRX transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
Shares: +160,000
Change %
Price: $0.000000^*
Shares after: 160,000
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 160,000
Exercise price: $3.43
Footnotes: F1

TTRX transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
Shares: +160,000
Change %
Price: $0.000000^*
Shares after: 160,000
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 160,000
Exercise price: $3.43
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest as follows: 25% will vest on the first anniversary of the grant date, with the remaining 75% vesting ratably over the following 36 months, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan.